Roswell Park Cancer Institute

What Roswell Park Cancer Institute does

Roswell Park Comprehensive Cancer Center (formerly Roswell Park Cancer Institute) is a non-profit, NCI-designated Comprehensive Cancer Center founded in 1898 and headquartered in Buffalo, New York. It is one of the first three NCI-designated cancer centers in the United States, the only one in Upstate New York, and has been rated "Exceptional" by the National Cancer Institute. The institution operates a full continuum of cancer services spanning prevention and screening, diagnosis, treatment (surgery, chemotherapy, radiation, immunotherapy, transplant and cellular therapy), clinical trials, and survivorship, supported by an advanced research infrastructure that includes bioanalytics, genomics, GMP facilities, translational imaging, and biorepository services. It employs 4,000+ staff and is led by President & CEO Candace S. Johnson, PhD.

Its technology and product footprint includes the EDDY mobile cancer screening vehicle (breast, lung, prostate screening), the MyRoswell patient portal, telehealth/virtual visits, specialty pharmacy services, mobile applications for both patients and referring physicians (RPMD), and proprietary clinical-stage immunotherapies including the SurVaxM peptide vaccine (with MimiVax), the GB-5267 MUC16 armored CAR T therapy (with Generate Biomedicines), and CAR-T work with Anixa Biosciences. The institution is recognized as a world leader in immune-based treatments and cancer vaccines.

Roswell Park generates revenue through patient care services (billed to insurers and patients, with treatment costs that can exceed $1M for advanced therapies), sponsored research and clinical trial agreements, and charitable grants. Go-to-market is sales-led via physician referrals, self-referral, and the Roswell Park Care Network — a 14+ affiliated-site alliance established in 2019 that extends cancer care, clinical trials, and telemedicine access across New York State through partners including St. Peter's Health Partners, St. Joseph's Health, Samaritan Medical Center, Ellis Medicine, Oneida Health, and Niagara Falls Memorial Medical Center. Additional community-facing distribution includes the EDDY mobile screening unit and Indigenous community navigation programs supported by grants from the Bristol Myers Squibb Foundation.

Name

Roswell Park Cancer Institute

Legal name

Roswell Park Comprehensive Cancer Center

Website

https://roswellpark.org

Company type

Private

Founded year

1898

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Roswell Park Comprehensive Cancer Center is a non-profit, NCI-designated Comprehensive Cancer Center in Buffalo, NY, providing the full continuum of cancer care — prevention, diagnosis, treatment including immunotherapy and CAR-T, clinical trials, and survivorship — to cancer patients across New York State through its main campus, mobile screening, and 14+ affiliated Care Network sites.

Ownership category

akta.pro rank

Product category

Comprehensive Cancer Care

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ), Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK)

Keywords

• Comprehensive cancer care
• Oncology treatment services
• Immunotherapy and vaccines
• Clinical trial research
• Cancer screening services

Headquarters

HQ city

Buffalo

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Comprehensive cancer treatment services including chemotherapy, immunotherapy, radiation therapy, surgery, and other oncology treatments billed to patients and insurance providers.
2. Clinical Trials: Research grants and sponsored research agreements for clinical trial conduct.
3. Foundation Grants: Grant funding from foundations such as Bristol Myers Squibb Foundation for specific programs and research initiatives.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Roswell Park Comprehensive Cancer Center is an NCI-designated comprehensive cancer center delivering the full spectrum of oncology services including surgery, chemotherapy, immunotherapy, radiation therapy, transplant and cellular therapy, clinical trials, survivorship care, and screening/diagnostic services. It operates the Roswell Park Care Network extending cancer care across New York State through 14+ affiliated community practice locations, and conducts translational research including novel cancer vaccines and CAR-T cell therapies.

Product overview

Roswell Park Comprehensive Cancer Center is a single, unified comprehensive cancer center offering integrated cancer care services. The organization provides a full continuum of care including prevention, diagnosis, treatment, and survivorship services. Key offerings include: EDDY mobile cancer screening bringing diagnostics to communities; immunotherapy and cellular therapy programs including CAR-T; the Survivorship Program with personalized care plans; Clinical Trials for experimental treatments; Virtual Visits for remote consultations; and the Roswell Park Care Network extending access across New York State. The center operates specialized facilities including the Scott Bieler Amherst Center and provides support services through patient portals, pharmacy services, and the Mirand Library for research. The institution emphasizes its status as the only NCI-designated comprehensive cancer center in Upstate New York, offering world-renowned expertise across all cancer types at every stage.

Differentiator

Problem solved

Functional benefit

Products and services

• Comprehensive Cancer Treatment Services Full-spectrum oncology care across all cancer types and stages including surgery, chemotherapy, radiation therapy, immunotherapy, transplant and cellular therapy, and supportive care services. Delivered at the main Buffalo campus for patients with suspicion or diagnosis of cancer.
• Immunotherapy and Cellular Therapy Program World-leading immune-based treatments and cancer vaccines including CAR-T cell therapy, checkpoint inhibitors, and novel cancer vaccines such as SurVaxM. Includes bone marrow and stem cell transplantation services.
• Clinical Trials Program Access to experimental treatments and therapies through participation in clinical research studies across multiple cancer types, including novel immunotherapy, vaccine, and CAR-T programs sponsored with biotech partners.
• EDDY Mobile Cancer Screening Mobile cancer screening vehicle offering breast, lung, and prostate cancer screening services, bringing screening capabilities directly to rural and underserved communities.
• Survivorship Program Comprehensive post-treatment care including personalized Survivorship Care Plans, annual visits, cancer screenings, symptom management, and wellness services for cancer survivors.
• Cancer Coach Program One-on-one support program pairing cancer patients with trained survivor mentors who provide guidance and emotional support throughout treatment.
• Genetic Testing and High Risk Screening Clinics Comprehensive genetic testing services for hereditary cancer syndromes and personalized risk assessment, plus specialized screening programs for high-risk individuals including breast, gynecologic, lung, and pancreas cancer screening clinics.
• Virtual Visits (Telehealth) Telehealth appointments allowing patients to consult with their Roswell Park care team remotely for follow-up visits and certain consultations.
• Roswell Park Care Network Alliance of 14+ affiliated medical providers across New York State delivering guideline-driven cancer care with access to Roswell Park's clinical trials, telemedicine, and treatment protocols in communities outside Buffalo.
• Oncology Pharmacy Services On-site specialty pharmacy providing oncology medications with same-day prescription refills and clinical pharmacy consultations, including an Amherst pharmacy location.
• Scott Bieler Amherst Center State-of-the-art 30,000+ square foot facility in Williamsville providing clinic visits, diagnosis, imaging, chemotherapy, infusions, pharmacy, and survivorship care for Western New York patients.

Quantifiable outcome

• NCI 'Exceptional' rating
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Partnerships

13 partnerships are on record, tiered core and minor.

• MimiVaxcoreStrategic or Co-development Partner · 7 May 2026Joint Phase 2 clinical trial evaluating SurVaxM peptide vaccine targeting survivin protein combined with temozolomide for patients with progressing metastatic neuroendocrine tumors. Phase 1 showed vaccine was well tolerated with measurable clinical benefit.
• St. Peter's Health PartnerscoreChannel Partner/ Reseller/ Distributor · 30 October 2025Roswell Park Care Network expansion to Albany region. St. Peter's Cancer Care Center offers breast, lung, colorectal, gastrointestinal and blood cancer care with access to Roswell Park's latest treatments, clinical trials, and telemedicine.
• St. Joseph's HealthcoreChannel Partner/ Reseller/ Distributor · 14 December 2023Cancer Care Service Line partnership bringing medical oncology services to Central New York (Syracuse). Provides access to latest treatment options, clinical trials, and telemedicine via Roswell Park.
• University of New Mexico Native American Budget and Policy InstitutecoreStrategic or Co-development PartnerCollaboration to adapt Roswell Park's patient navigation program for Indigenous communities, including Pueblo Nations in New Mexico.
• Generate BiomedicinescoreStrategic or Co-development PartnerCollaboration on GB-5267, a MUC16 armored CAR T therapy targeting ovarian cancer. First patient dosing planned for H2 2026. Generate is also developing GB-0895 (Phase 3 severe asthma) and GB-4362 (FDA Fast Track MMAE neutralizer).
• Anixa BiosciencescoreStrategic or Co-development PartnerCollaboration on clinical-stage immunotherapy programs. Ovarian cancer CAR-T therapy lira-cel showing positive survival observations in Phase 1 trial. Breast cancer vaccine program completed Phase 1 with all primary endpoints met.
• Biovica InternationalminorStrategic or Co-development PartnerPublished positive clinical trial data from studies at Roswell Park Comprehensive Cancer Center. Strategic commercial agreement with NCI Center in USA.
• Samaritan Medical CentercoreChannel Partner/ Reseller/ DistributorRoswell Park Samaritan Health affiliation increases capabilities and resources for patients in Watertown region. Provides access to latest therapies and quality medical oncology services at Walker Center for Cancer Care.
• Oneida Health Cancer CarecoreChannel Partner/ Reseller/ DistributorProvides Central New York access to Roswell Park cancer care including expert diagnosis, treatment planning, medical oncology, chemotherapy and infusion services.
• Niagara Falls Memorial Medical CentercoreChannel Partner/ Reseller/ DistributorCollaboration specializing in diagnosis and care of cancer and blood disorders. Offers lung cancer screening, on-site chemotherapy and infusion therapy with access to Roswell Park clinical trials.
• Ellis MedicinecoreChannel Partner/ Reseller/ DistributorPartnership brings nationally-ranked cancer center innovation to Schenectady with clinical trials and medical oncology services through Roswell Park specialists.
• Intermountain HealthminorStrategic or Co-development PartnerPatient navigator programs and telehealth initiatives to bridge healthcare gaps in Indigenous communities.
• Messengers for HealthminorStrategic or Co-development PartnerPatient navigator programs and telehealth initiatives to bridge healthcare gaps in Indigenous communities.

Scale indicators4 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• Memorial Sloan Kettering Cancer Center: NCI-designated comprehensive cancer center in New York City and the dominant U.S. oncology referral institution. Directly comparable to Roswell Park in scope (NCI CCC designation, full care continuum, immunotherapy leadership, clinical trials infrastructure) but operates at substantially larger scale and national reach.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI comprehensive cancer center in Boston with global leadership in adult and pediatric oncology, immunotherapy research, and clinical trials. Comparable to Roswell Park as a non-profit NCI CCC with deep translational research and CAR-T expertise.
• MD Anderson Cancer Center: University of Texas NCI-designated comprehensive cancer center, consistently the largest U.S. cancer hospital by volume. Directly comparable in NCI CCC status, research breadth, and clinical-trial volume; represents the upper bound of cancer-center scale.
• Johns Hopkins Sidney Kimmel Cancer Center: NCI comprehensive cancer center in Baltimore with strong translational research and immunotherapy programs. Directly comparable to Roswell Park as a non-profit NCI CCC delivering the full continuum of cancer care including CAR-T and cancer vaccines.
• Fred Hutchinson Cancer Center: Seattle-based NCI comprehensive cancer center globally recognized for bone marrow transplantation and cellular therapy research, including pioneering CAR-T work. Directly comparable to Roswell Park's transplant and cellular therapy program and immunotherapy leadership.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated comprehensive cancer center operating across Mayo's multi-state integrated health system. Comparable to Roswell Park in NCI CCC status, multi-site care delivery model, and clinical trials breadth, though at materially larger scale.
• UCSF Helen Diller Family Comprehensive Cancer Center: University of California NCI comprehensive cancer center with strong translational science and immunotherapy programs. Directly comparable to Roswell Park as an academic NCI CCC with CAR-T and cancer vaccine pipelines.
• City of Hope Comprehensive Cancer Center: NCI-designated comprehensive cancer center in Southern California with nationally recognized transplant and cellular therapy programs. Closely comparable to Roswell Park on cell therapy leadership and clinical trials activity.
• H. Lee Moffitt Cancer Center & Research Institute: Florida-based NCI comprehensive cancer center focused exclusively on cancer care and research. Comparable to Roswell Park as a non-profit, single-disease NCI CCC with a strong research enterprise and clinical trials infrastructure.
• Perlmutter Cancer Center (NYU Langone Health): NCI-designated comprehensive cancer center within NYU Langone in New York City, offering the full continuum of oncology care including immunotherapy and CAR-T. Comparable to Roswell Park as a NY-based NCI CCC competing in the same metropolitan referral market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/RoswellPark
• YouTubeyoutube.com/rpcicreative
• Facebookfacebook.com/RoswellPark
• LinkedInlinkedin.com/company/roswell-park-cancer-institute
• Instagraminstagram.com/roswellpark

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries4 records

Funding overview

Funding rounds12 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roswell Park Cancer Institute